Lesions in relapsing-remitting MS patients arise from a complex interplay of both CD4+ and CD8+ T cells, with B cells and innate immune cells playing critical roles in orchestrating T cell responses. The gene discussed is CD8A; the disease is relapsing-remitting multiple sclerosis.